Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,480 | 17 | 99.3% |
| Education | $10.24 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amarin Pharma Inc. | $274.23 | 3 | $0 (2019) |
| Alcon Laboratories Inc | $146.45 | 1 | $0 (2017) |
| Glaukos Corporation | $145.91 | 1 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $142.34 | 2 | $0 (2017) |
| Regeneron Pharmaceuticals, Inc. | $125.00 | 1 | $0 (2017) |
| Horizon Pharma plc | $124.99 | 1 | $0 (2018) |
| Dexcom, Inc. | $99.20 | 1 | $0 (2023) |
| Synergy Pharmaceuticals Inc | $96.69 | 1 | $0 (2017) |
| Abbott Laboratories | $95.56 | 1 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $70.43 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $99.20 | 1 | Dexcom, Inc. ($99.20) |
| 2022 | $18.66 | 1 | Merck Sharp & Dohme LLC ($18.66) |
| 2020 | $95.56 | 1 | Abbott Laboratories ($95.56) |
| 2019 | $177.59 | 2 | Amarin Pharma Inc. ($142.59) |
| 2018 | $225.85 | 3 | Horizon Pharma plc ($124.99) |
| 2017 | $873.81 | 10 | Alcon Laboratories Inc ($146.45) |
All Payment Transactions
18 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/06/2023 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $99.20 | General |
| Category: Endocrinology | ||||||
| 09/29/2022 | Merck Sharp & Dohme LLC | DIFICID (Drug), ZERBAXA, RECARBRIO | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 03/13/2020 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $95.56 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/10/2019 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $35.00 | General |
| Category: Endocrinology | ||||||
| 03/08/2019 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $142.59 | General |
| Category: Hypertriglyceridemia | ||||||
| 11/11/2018 | Radius Health, Inc. | Tymlos (Biological) | Food and Beverage | In-kind items and services | $33.00 | General |
| Category: Endocrinology | ||||||
| 04/17/2018 | Horizon Pharma plc | TEPRO (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: TEPRO | ||||||
| 03/30/2018 | SANOFI-AVENTIS U.S. LLC | SOLIQUA (Drug) | Food and Beverage | In-kind items and services | $67.86 | General |
| Category: DIABETES | ||||||
| 11/21/2017 | Synergy Pharmaceuticals Inc | Trulance (Drug) | Food and Beverage | In-kind items and services | $96.69 | General |
| Category: Gastroenterology | ||||||
| 11/18/2017 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.35 | General |
| Category: Central Nervous System | ||||||
| 10/13/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $70.43 | General |
| Category: Respiratory | ||||||
| 10/06/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $78.87 | General |
| Category: DIABETES | ||||||
| 09/27/2017 | Glaukos Corporation | ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) | Food and Beverage | In-kind items and services | $145.91 | General |
| Category: Glaucoma | ||||||
| 07/21/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $63.47 | General |
| 05/06/2017 | Alcon Laboratories Inc | ORA (Device), LenSx | Food and Beverage | In-kind items and services | $146.45 | General |
| Category: Ophthalmology | ||||||
| 05/06/2017 | Regeneron Pharmaceuticals, Inc. | EYLEA AFLIBERCEPT INJECTION (Biological) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: OPHTHALMOLOGY | ||||||
| 02/03/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $121.40 | General |
| Category: Hypertriglyceridemia | ||||||
| 02/03/2017 | Amarin Pharma Inc. | Vascepa (Drug) | Education | In-kind items and services | $10.24 | General |
| Category: Hypertriglyceridemia | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 48 | 55 | $9,700 | $4,148 |
| 2022 | 5 | 139 | 162 | $29,310 | $12,141 |
| 2021 | 5 | 163 | 201 | $34,340 | $14,662 |
| 2020 | 7 | 247 | 298 | $48,395 | $21,976 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 20 | 26 | $5,200 | $2,378 | 45.7% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 16 | 16 | $3,200 | $1,426 | 44.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 12 | 13 | $1,300 | $344.03 | 26.5% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 50 | 70 | $13,710 | $6,084 | 44.4% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 36 | 36 | $7,200 | $3,590 | 49.9% |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | Office | 2022 | 11 | 12 | $2,400 | $1,104 | 46.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 28 | 29 | $2,900 | $720.28 | 24.8% |
| 92083 | Exam of visual field with extended testing | Office | 2022 | 14 | 15 | $3,100 | $642.61 | 20.7% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 64 | 94 | $16,970 | $8,115 | 47.8% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2021 | 33 | 33 | $6,370 | $2,726 | 42.8% |
| 92235 | Imaging of blood vessels in back of eye using fluorescein dye | Office | 2021 | 22 | 25 | $5,000 | $2,495 | 49.9% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 33 | 38 | $3,800 | $990.47 | 26.1% |
| 92250 | Photography of the retina | Office | 2021 | 11 | 11 | $2,200 | $335.95 | 15.3% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 63 | 91 | $14,470 | $8,872 | 61.3% |
| 92004 | Eye and medical examination for diagnosis and treatment, new patient, 1 or more visits | Office | 2020 | 45 | 45 | $7,850 | $3,440 | 43.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 17 | 19 | $5,700 | $3,150 | 55.3% |
| 92235 | Imaging of blood vessels in back of eye using fluorescein dye | Office | 2020 | 22 | 26 | $5,200 | $2,399 | 46.1% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 54 | 62 | $6,200 | $1,701 | 27.4% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 33 | 38 | $5,525 | $1,554 | 28.1% |
| 92083 | Measurement of field of vision during daylight conditions | Office | 2020 | 13 | 17 | $3,450 | $860.19 | 24.9% |
About Dr. Lung Chang, MD
Dr. Lung Chang, MD is a Ophthalmology healthcare provider based in Alhambra, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1013935444.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lung Chang, MD has received a total of $1,491 in payments from pharmaceutical and medical device companies, with $99.20 received in 2023. These payments were reported across 18 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,480).
As a Medicare-enrolled provider, Chang has provided services to 597 Medicare beneficiaries, totaling 716 services with total Medicare billing of $52,928. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Alhambra, CA
- Active Since 07/17/2006
- Last Updated 07/08/2007
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1013935444
Products in Payments
- Vascepa (Drug) $274.23
- ORA (Device) $146.45
- ISTENT TRABECULAR MICRO-BYPASS STENT SYSTEM (Device) $145.91
- EYLEA AFLIBERCEPT INJECTION (Biological) $125.00
- TEPRO (Drug) $124.99
- DEXCOM G7 GSS (161) (Medical Supply) $99.20
- Trulance (Drug) $96.69
- Confirm Rx (Device) $95.56
- JARDIANCE (Drug) $78.87
- BEVESPI AEROSPHERE (Drug) $70.43
- Tymlos (Biological) $68.00
- SOLIQUA (Drug) $67.86
- DIFICID (Drug) $18.66
- AUSTEDO (Drug) $15.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Alhambra
Mr. Kevin Choy, M.d, M.D
Ophthalmology — Payments: $5,206
Dr. Beelein Lin, M.d, M.D
Ophthalmology — Payments: $1,575
Dr. Grace Liu, M.d, M.D
Ophthalmology — Payments: $440.21
Dr. Dik Cheung, M.d, M.D
Ophthalmology — Payments: $120.11
Kunbee Chang, Dvm, DVM
Ophthalmology